Advertisements


Acceleron"s Unique Pipeline Looks Undervalued

Acceleron"s Unique Pipeline Looks Undervalued.....»»

Category: topSource: seekingalphaOct 12th, 2017

Redhill BioPharma: Highly De-Risked And Undervalued With A Deep Pipeline

Redhill BioPharma: Highly De-Risked And Undervalued With A Deep Pipeline.....»»

Category: topSource: seekingalphaSep 22nd, 2017

RedHill BioPharma: Highly De-Risked And Undervalued With A Deep Pipeline

RedHill BioPharma: Highly De-Risked And Undervalued With A Deep Pipeline.....»»

Category: topSource: seekingalphaSep 22nd, 2017

Merck, Allergan, Lilly: Top Pharma Picks

Merck is a top pick in U.S. Pharma. Allergan’s pipeline is undervalued. Lilly has potential drivers......»»

Category: topSource: barronsAug 15th, 2017

Kinder Morgan: "Outsider" Behaviour At An Undervalued Pipeline Operator

Kinder Morgan: "Outsider" Behaviour At An Undervalued Pipeline Operator.....»»

Category: topSource: seekingalphaAug 14th, 2017

Acceleron (XLRN) Kidney Cancer Candidate Fails in Phase II

Acceleron Pharma Inc.'s (XLRN) announced disappointing results from a phase II study evaluating its pipeline candid.....»»

Category: topSource: zacksJun 14th, 2017

Celgene & Acceleron Complete Enrollment on Thalassemia Drug

Celgene Corporation (CELG) and Acceleron Pharma Inc. (XLRN) announced that the companies have completed target enrollment in the phase III studies, MEDALIST and BELIEVE on pipeline candidate luspatercept. Celgene Corporation CELG and.....»»

Category: topSource: zacksJun 2nd, 2017

Alaris - An Undervalued Dividend Streaming Company In A Unique Niche

Alaris - An Undervalued Dividend Streaming Company In A Unique Niche.....»»

Category: topSource: seekingalphaMay 7th, 2017

Undervalued Vectrus Inc, FCF/Price Yield 15%, Solid Backlog and Prospective Pipeline

One of the cheapest stocks in our All Investable – Stock Screener is Vectrus Inc (NYSE:VEC). With a market cap of $240 million, this micro-cap remains undiscovered by a lot of investors and too small for investment by large inst.....»»

Category: blogSource: valuewalkMar 12th, 2017

BioLineRx - Undervalued With Significant Pipeline, Large Pharma Collaborations, And Strong Balance Sheet

BioLineRx - Undervalued With Significant Pipeline, Large Pharma Collaborations, And Strong Balance Sheet.....»»

Category: topSource: seekingalphaFeb 15th, 2017

DSW: Materially Undervalued With Unique Strengths

DSW: Materially Undervalued With Unique Strengths.....»»

Category: topSource: seekingalphaFeb 7th, 2017

GW Pharma Cannabinoid Pipeline Undervalued By The Market

GW Pharma Cannabinoid Pipeline Undervalued By The Market.....»»

Category: topSource: seekingalphaDec 14th, 2016

Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus

This week, several biotech companies were present at the annual meeting of the American Society of Hematology (ASH) with data on approved and pipeline candidates. Several companies like Celgene (Read more: Acceleron, Celgene Present Myelodyspla.....»»

Category: topSource: zacksDec 7th, 2016

Acceleron: A Celgene Partner With A Promising Pipeline

Acceleron: A Celgene Partner With A Promising Pipeline.....»»

Category: topSource: seekingalphaSep 12th, 2016

Why Celgene Corporation (CELG) Can Finish 2016 in the Black

InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips With Celgene's increased guidance and a strong pipeline, CELG stock looks undervalued at current prices. The post Why Celgene Corporation (CELG) Can Finish 2016 in the Black appea.....»»

Category: topSource: investorplaceSep 9th, 2016

American Hotel Income Properties: Undervalued And Unique With Strong Fundamentals

American Hotel Income Properties: Undervalued And Unique With Strong Fundamentals.....»»

Category: topSource: seekingalphaSep 2nd, 2016

Allergan: A Splitting Headache?

J.P. Morgan's Chris Schott says a sum-of-the-parts analysis shows that Allergan is “highly undervalued." Still, he says it's too early to consider a split......»»

Category: blogSource: barrons1 hr. 8 min. ago

Pipeline Bomb: Analysts Review Celgene"s Crohn"s Diseases Failure

Celgene Corporation (NASDAQ: CELG) stock plummeted 10 percent Friday after the company reported that its testing of GED-0301 for treatment of Crohn’s disease has failed to meet its e.....»»

Category: blogSource: benzinga1 hr. 8 min. ago

Hawaii boat crash spurs new concerns about foreign fishermen

A boat that ran aground off Honolulu while transporting foreign fishermen to work in Hawaii's commercial fishing industry has raised new questions about the safety and working conditions for foreign laborers in this unique U.S. fleet......»»

Category: topSource: foxnews1 hr. 38 min. ago

Rosneft to take control of Kurdish pipeline

Russia's bi.....»»

Category: videoSource: reuters2 hr. 38 min. ago

Celgene"s Pipeline In Question After GED Failure

After announcing the termination of its mongerson program for Crohn’s disease, Celgene Corporation (NASDAQ: CELG) is looking more and.....»»

Category: blogSource: benzinga3 hr. 53 min. ago